JOSE LUIS
GORRIZ TERUEL
CONTRATADO/A DOCTOR/A
Karolinska Institute
Estocolmo, SueciaPublicacions en col·laboració amb investigadors/es de Karolinska Institute (8)
2023
-
Sevelamer Use and Mortality in People with Chronic Kidney Disease Stages 4 and 5 Not on Dialysis
Journal of Clinical Medicine, Vol. 12, Núm. 24
2021
-
Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study
Journal of Nephrology, Vol. 34, Núm. 4, pp. 1189-1199
2019
-
Serum phosphate optimal timing and range associated with patients survival in haemodialysis: The COSMOS study
Nephrology Dialysis Transplantation, Vol. 34, Núm. 4, pp. 673-681
2018
-
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe
Kidney International, Vol. 93, Núm. 6, pp. 1432-1441
-
The effect of high-volume online haemodiafiltration on nutritional status and body composition: The ProtEin Stores prEservaTion (PESET) study
Nephrology Dialysis Transplantation, Vol. 33, Núm. 7, pp. 1223-1235
2013
-
COSMOS: The dialysis scenario of CKD-MBD in Europe
Nephrology Dialysis Transplantation, Vol. 28, Núm. 7, pp. 1922-1935
-
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients
Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733
-
Use of phosphate-binding agents is associated with a lower risk of mortality
Kidney International, Vol. 84, Núm. 5, pp. 998-1008